reconstitute tesamorelin: Frequently asked questions

Contact the supplier immediately and request a replacement vial before reconstituting. Lyophilised tesamorelin is stable at room temperature (20–25°C) for approximately 2–3 weeks, but you have no way to verify how long it sat at elevated temperature during shipping or whether it experienced brief excursions above 30°C in a delivery truck or mailbox. Peptide suppliers ship with temperature data loggers in some cases—request the shipping temperature record if available. If the powder appears discolored (yellow, brown, or gray rather than white), shows moisture inside the vial, or has separated from a solid cake into loose particles, temperature damage has occurred and the peptide should not be used. At Real Peptides, every shipment includes cold chain packaging designed to maintain sub-8°C temperatures for up to 72 hours in transit, but carrier delays occasionally extend delivery windows beyond this threshold. When in doubt, replace the vial—reconstituting compromised peptide wastes bacteriostatic water, syringe supplies, and researcher time with zero return.

Discard the vial immediately—cloudiness indicates irreversible protein aggregation and the peptide is no longer bioactive. Aggregation occurs when the peptide's tertiary structure unfolds and individual molecules clump together through hydrophobic interactions, forming visible particulates or diffuse cloudiness. This happens when bacteriostatic water is injected too quickly, when the vial is shaken rather than swirled, or when the lyophilised powder experienced temperature excursion above 25°C during shipping. No amount of additional swirling, heating, or time will restore clarity or bioactivity. The growth hormone-releasing epitope—the specific amino acid sequence that binds to GHRH receptors in the anterior pituitary—requires precise three-dimensional folding to function, and aggregated peptides have lost this structure permanently.

Use a medical-grade cooling case designed for peptide or insulin transport that maintains 2–8°C without freezing. Standard ice packs placed directly against the vial can freeze the solution, and even a single freeze-thaw cycle causes 40–60% potency loss through ice crystal-induced mechanical disruption. Purpose-built cooling wallets like the FRIO use evaporative cooling technology that holds temperature between 4–6°C for 36–48 hours without requiring ice, electricity, or refrigeration. For researchers conducting field work or traveling between facilities, these cases are non-negotiable. If the reconstituted tesamorelin reaches room temperature for more than four hours—common during long flights or road trips without proper cooling—assume at least 30–40% potency degradation and adjust your protocol accordingly or reconstitute a fresh vial upon arrival.

Allow the vial to sit completely undisturbed for two full minutes, then inspect for cloudiness under good lighting. If the solution appears clear after gentle swirling, the peptide likely survived without significant denaturation—fast injection creates shear stress, but brief exposure may not exceed the peptide's mechanical tolerance threshold. If any cloudiness or particulates are visible, the peptide has aggregated and should be discarded. The challenge is that partial denaturation—where 20–40% of peptide molecules aggregate but the solution remains visually clear—cannot be detected without laboratory spectroscopy. In our experience working with researchers across hundreds of peptide reconstitutions, visible cloudiness appears in fewer than 15% of cases where technique errors occurred, meaning most mechanical damage goes undetected until the peptide fails to produce expected results in application. This is why reconstitution technique matters so critically—you cannot visually confirm success in most cases.

Immediate turbulence doesn't guarantee aggregation, but it increases risk significantly. Allow the vial to sit undisturbed for 2–3 minutes rather than the standard 60–90 seconds. This gives disrupted peptides additional time to refold. Inspect the solution closely for cloudiness or particulates after 5 minutes. If the solution is clear, proceed cautiously. But understand that partial aggregation may have occurred at a level not visible to the naked eye. Consider using a lower dose for the first administration to assess response, or reconstitute a new vial if precision is critical.

Gently roll the vial between your palms for 10–15 seconds. Do not shake. Rolling creates rotational flow without turbulence. If visible powder or clumps persist after gentle rolling, allow the vial to sit undisturbed in the refrigerator for 5–10 minutes and check again. Peptide blends with different solubility profiles (Tesamorelin is more hydrophobic than Ipamorelin) occasionally require extended passive dissolution time. If clumps remain after 15 minutes total, the powder may have aggregated during storage before reconstitution. This indicates cold chain failure during shipping. Do not use the vial.

Reconstituted Tesamorelin + Ipamorelin blend tolerates up to 48 hours at controlled room temperature (18–25°C) without significant degradation, but this is an emergency allowance, not a recommended practice. For travel, use an insulin cooler or medical-grade cold pack that maintains 2–8°C. Avoid gel ice packs that freeze solid. Direct contact with frozen packs can cause localized freezing in the vial. Wrap the vial in a small towel or padding inside the cooler to buffer temperature fluctuations. Airport security allows peptide vials and syringes when accompanied by a research protocol document or prescription equivalent. TSA regulations permit medically necessary liquids in carry-on baggage without volume restrictions when declared at screening.

Discard the vial immediately. Cloudiness indicates either aggregation or bacterial contamination, and neither is reversible. This outcome almost always traces to one of three causes: (1) contamination during reconstitution due to inadequate stopper sterilization, (2) temperature excursion above 8°C during storage, or (3) repeated freeze-thaw cycles if someone mistakenly placed the vial in a freezer section. Review your reconstitution and storage technique before opening a new vial. If cloudiness develops in multiple vials prepared using identical technique, the bacteriostatic water itself may be contaminated. Source fresh bacteriostatic water from a verified supplier like Real Peptides.